Dishman Carbogen [DCAL] vs OneSource Specialty [ONESOURCE] Detailed Stock Comparison

Dishman Carbogen Amcis Ltd.

NSE
Loading...

OneSource Specialty Pharma Inc.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Dishman Carbogen Amcis Ltd. wins in 13 metrics, OneSource Specialty Pharma Inc. wins in 4 metrics, with 0 ties. Dishman Carbogen Amcis Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dishman Carbogen Amcis Ltd. OneSource Specialty Pharma Inc. Better
P/E Ratio (TTM) 22.30 936.63 Dishman Carbogen Amcis Ltd.
Price-to-Book Ratio 0.42 3.11 Dishman Carbogen Amcis Ltd.
Debt-to-Equity Ratio 40.20 21.93 OneSource Specialty Pharma Inc.
PEG Ratio -0.16 42.24 OneSource Specialty Pharma Inc.
EV/EBITDA 9.62 40.79 Dishman Carbogen Amcis Ltd.
Profit Margin (TTM) 4.25% 1.42% Dishman Carbogen Amcis Ltd.
Operating Margin (TTM) 3.99% -18.02% Dishman Carbogen Amcis Ltd.
EBITDA Margin (TTM) 3.99% N/A N/A
Return on Equity 0.06% -0.31% Dishman Carbogen Amcis Ltd.
Return on Assets (TTM) 0.03% -0.24% Dishman Carbogen Amcis Ltd.
Free Cash Flow (TTM) $1.58B $-1.96B Dishman Carbogen Amcis Ltd.
1-Year Return -33.95% -20.38% OneSource Specialty Pharma Inc.
Price-to-Sales Ratio (TTM) 0.95 13.01 Dishman Carbogen Amcis Ltd.
Enterprise Value $46.55B $195.90B OneSource Specialty Pharma Inc.
EV/Revenue Ratio 1.66 13.80 Dishman Carbogen Amcis Ltd.
Gross Profit Margin (TTM) 80.34% 67.50% Dishman Carbogen Amcis Ltd.
Revenue per Share (TTM) $179 $124 Dishman Carbogen Amcis Ltd.
Earnings per Share (Diluted) $7.58 $1.72 Dishman Carbogen Amcis Ltd.
Beta (Stock Volatility) 0.40 N/A N/A

Dishman Carbogen Amcis Ltd. vs OneSource Specialty Pharma Inc. Stock Performance Analysis

Loading Price Chart...

DCAL
ONESOURCE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dishman Carbogen Amcis Ltd.-2.38%-2.24%-7.21%9.02%-19.76%-29.73%
OneSource Specialty Pharma Inc.0.68%-6.58%-11.52%8.72%0.44%-9.19%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dishman Carbogen Amcis Ltd.-33.95%46.77%-6.77%33.46%290.77%118.12%
OneSource Specialty Pharma Inc.-20.38%-5.70%-5.70%-5.70%-5.70%-5.70%

Performance & Financial Health Analysis: Dishman Carbogen Amcis Ltd. vs OneSource Specialty Pharma Inc.

MetricDCALONESOURCE
Market Information
Market Cap i₹26.50B₹202.76B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i337,2641,038,625
90 Day Avg. Volume i517,904610,058
Last Close₹180.24₹1,623.40
52 Week Range₹128.50 - ₹321.95₹1,057.00 - ₹2,248.00
% from 52W High-44.02%-27.78%
All-Time High₹396.40 (Jan 22, 2018)₹2,248.00 (Jun 18, 2025)
% from All-Time High-54.53%-27.78%
Growth Metrics
Quarterly Revenue Growth0.06%-0.26%
Quarterly Earnings Growth-0.09%N/A
Financial Health
Profit Margin (TTM) i0.04%0.01%
Operating Margin (TTM) i0.04%-0.18%
Return on Equity (TTM) i0.00%0.00%
Debt to Equity (MRQ) i40.2021.93
Cash & Liquidity
Book Value per Share (MRQ)₹405.67₹518.08
Cash per Share (MRQ)₹40.41₹14.56
Operating Cash Flow (TTM) i₹-199,700,000₹-2,152,760,000
Levered Free Cash Flow (TTM) i₹32.40M₹-179,710,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00N/A

Valuation & Enterprise Metrics Analysis: Dishman Carbogen Amcis Ltd. vs OneSource Specialty Pharma Inc.

MetricDCAL (Apr 26, 2026)ONESOURCE (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i22.30936.63
Forward P/E i13.5242.24
PEG Ratio i-0.1642.24
Price to Sales (TTM) i0.9513.01
Price to Book (MRQ) i0.423.11
Market Capitalization
Market Capitalization i₹26.50B₹202.76B
Enterprise Value i₹46.55B₹195.90B
Enterprise Value Metrics
Enterprise to Revenue i1.6613.80
Enterprise to EBITDA i9.6240.79
Risk & Other Metrics
Beta i0.40N/A
Book Value per Share (MRQ) i₹405.67₹518.08

Financial Statements Comparison: Dishman Carbogen Amcis Ltd. vs OneSource Specialty Pharma Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDCAL (2025)ONESOURCE (2025)
Revenue/Sales i26.42B14.45B
Cost of Goods Sold i5.26B4.35B
COGS % of Revenue i19.9%30.1%
Gross Profit i21.16B10.10B
Gross Margin i80.1%69.9%
Research & Development iN/A20.49M
Operating Income (EBIT) i1.46B1.90B
Operating Margin i5.5%13.2%
EBITDA i4.83B4.71B
EBITDA Margin i18.3%32.6%
Pre-Tax Income i193.10M-670.66M
Pre-Tax Income % of Revenue i0.7%-4.6%
Income Tax i160.70M-497.85M
Income Tax % of Revenue i0.6%-3.4%
Net Income (Profit) i32.40M-179.71M
Profit Margin i0.1%-1.2%

Balance Sheet & Liquidity Metrics

MetricDCAL (2025)ONESOURCE (2025)
Cash & Equivalents i2.86B1.56B
Total Current Assets i22.00B10.86B
Total Current Assets % of Revenue i83.3%75.2%
Total Current Liabilities i19.25B11.14B
Total Current Liabilities % of Revenue i72.9%77.1%
Long-Term Debt i13.90B3.83B
Long-Term Debt % of Revenue i52.6%26.5%
Total Shareholders Equity i58.32B58.81B
Retained Earnings i2.13B-18.43B
Retained Earnings % of Revenue i8.1%-127.6%
Property, Plant & Equipment i10.27B8.97B

Cash Flow Statement Comparison

MetricDCAL (2025)ONESOURCE (2025)
Operating Cash Flow i-199.70M-2.15B
Operating Cash Flow % of Revenue i-0.8%-14.9%
Capital Expenditures i-2.15BN/A
Free Cash Flow i1.58B-1.96B
FCF Margin i6.0%-13.6%
Debt Repayment i-1.10B-6.31B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDCALONESOURCE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i156.78M114.64M
Float Shares i54.95M70.43M
% Held by Insiders i69.30%38.63%
% Held by Institutions i2.41%26.67%
% Held by Public i28.29%34.70%

Dividend Analysis & Yield Comparison: Dishman Carbogen Amcis Ltd. vs OneSource Specialty Pharma Inc.

MetricDCALONESOURCE
Last 12-Month Dividend i₹0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00N/A
Ex-Dividend DateN/AN/A